Glaucoma. Glaucoma
Conditions
Interventions
Intervention 1: Intervention group:Hab_AlZahab ( daymolex ) produced by Daymond pharmaceutical company ? a500 mg tablet every night, for 4 weeks. Intervention 2: Control group: Placebo tablet produ
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Aged 18 to 85 years old, Diagnosed with Chronic Glaucoma, Signed Written Informed Consent Form, Capable of Cooperation and Responding to Questions.
Exclusion criteria
Exclusion criteria: Allergy to Aleovera Chronic Systemic Diseases : Uncontrolled Hypertension Cardiac disease? Gastrointestinal (GI) disease , Malignancy , Abdominal Pain with Unknown Cause , Obstructive and Inflammatory Bowel Disease , Acute Glaucoma , Ophthalmic Surgery , Pregnancy , Breast Feeding , Taking Corticosteroids ,Diuretics and .Thiazids Drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure. Timepoint: 0,1,2,4 weeks after intervention. Method of measurement: Slit lamps. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: Before intervention and 7,14,21 days after intervention. Method of measurement: ?Asking.;Abdominal pain. Timepoint: Before intervention and 7,14.21 days after intervention. Method of measurement: Asking.;Diarrhea. Timepoint: Before intervention and 7,14.21 days after intervention. Method of measurement: Asking. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAssie Jokar
Mazandaran University of Medical Sciences
Outcome results
None listed